| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745979 | Parkinsonism & Related Disorders | 2013 | 5 Pages |
Abstract
After two years of follow-up, STN-DBS in the “off” medication was associated with a reduction in the frequency and severity of NMF. These results will need to be confirmed in controlled studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Sara Ortega-Cubero, Pedro Clavero, Cecilia Irurzun, Rafael Gonzalez-Redondo, Jorge Guridi, Jose A. Obeso, Maria C. Rodriguez-Oroz,